Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2899-2911
Author(s):
Liangkun You, Changyu Liu, Hexiao Tang, Yongde Liao and Shengling Fu
Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2881-2898
Author(s):
Christine Heinzle, Zeynep Erdem, Jakob Paur, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger and Brigitte Marian
CD95 Signaling in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2809-2818
Author(s):
Angel J. De la Rosa, Miguel A. Gomez, Salvador Morales, Francisco J. Padillo and Jordi Muntane
Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2637-2647
Author(s):
Ngoc-Ha T. Dang, Arvind K. Singla, Emily M. Mackay, Frank R. Jirik and Aalim M. Weljie
Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
380-393
Author(s):
Shijun Zhu, Terry W. Moore, Nao Morii, Randy B. Howard, Richard F. Arrendale, Prabhakar Reddy, Taylor J. Evers, Hongzheng Zhang, Gabriel Sica, Zhuo G. Chen, Aiming Sun, Haian Fu, Fadlo R. Khuri, Dong M. Shin, James P. Snyder and Mamoru Shoji
PET Imaging with [68Ga]NOTA-RGD for Prostate Cancer: A Comparative Study with [18F]Fluorodeoxyglucose and [18F]Fluoroethylcholine
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
371-379
Author(s):
Ina Israel, Dominik Richter, Jochen Stritzker, Michaela van Ooschot, Ulrike Donat, Andreas K. Buck and Samuel Samnick
Imaging Requirements for Personalized Medicine: The Oncologists Point of View
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2234-2249
Author(s):
V. Kruse, S. Van Belle and V. Cocquyt
Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2308-2318
Author(s):
Gilles Mees, Mike Sathekge, Alex Maes and Christophe Van de Wiele
Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2293-2307
Author(s):
Samantha Y. A. Terry, Mark Rijpkema, Keelara Abiraj, Winette T. van der Graaf, Wim J. Oyen and Otto C. Boerman
Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
673-687
Author(s):
Jian-Feng Tang, Qing Wen, Jian Sun, Wei-Ming Zhang and Hai-Liang Zhu